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In the search for potential anticancer agents from fruits, the present research work was carried out to examine the in 
vitro cytotoxic potential of seed part of Carissa carandas (karonda) and Syzygium cumini (jamun) against nine human 
cancer cell lines from eight different origins namely MCF-7, T-47D (breast), SF-295 (CNS), HCT-116 (colon), A-549 
(lung), MDA-MB-435 (melanoma), OVCAR-5 (ovary), PC-3 (prostate) and A-498 (renal). Methanolic extracts were used as 
test material and anticancer activity was determined via SRB assayat 100 μg/mL. Results revealed that seeds suppressed the 
proliferation of human cancer cells with growth inhibition range of 78-100% (karonda) and 71-93% (jamun). Karonda seeds 
exhibited 100% growth inhibition of A-549 and OVCAR-5 cancer cells where as jamun seeds displayed 93% growth 
inhibition of SF-295 cancer cells. The seeds were then evaluated at lower concentrations of 50, 30, 10 and 1 μg/mL in which 
seeds exhibit significant in vitro cytotoxic effect against lung cancer cells (A-549). Further, IC50 values were calculated and it was observed that seed extracts from both the fruits showed IC50<10 in case of lung cancer cells whereas karonda seed extract also showed IC50<10 in case of colon cancer cells. To conclude, karonda and jamun seeds possess certain constituents with cytotoxic properties that can be used to develop anticancer agents especially for lung cancer therapy and to 
provide a great service to cancer patients, further studies are required for the isolation of active ingredients from these seeds. 
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Cancer is one of the most life threatening diseases, 
which represents a substantial burden in the 
community and appears to be a prime cause of 
concern. Multidisciplinary scientific investigations are 
making best efforts to combat the disease, but the 
sure-shot, perfect cure is yet to be brought into the 
world of medicine. Fruits consumed in our daily diet 
could be a solution to this deadly disease by providing 
chemoprotective and chemotherapeutic remedy. 
C. carandas is a large dichotomously branched 
evergreen shrub with short stem and strong thorns in 
pairs1, that grows well under tropical and sub tropical 
climatic conditions2. The plant is widely used 
throughout India in the treatment of scabies, intestinal 
worms, pruritus and its fruit have been studied for 
analgesic, anti-inflammatory3 and lipase4 activity. The 
karonda fruit is an astringent, antiscorbutic and its 
root extract is known to have anti-inflammatory and 
antipyretic properties5. Chloroform extract of karonda 
leaves showed good anticancer activity against Caov-
3 (ovarian carcinoma) while the n-hexane extract of 
the unripe fruit showed remarkable activity against 
lung cancer cells6,7,8,9. 
S. cumini is a widely distributed forest tree in India 
and other tropical/subtropical regions of the world. Its 
fruit is a very rich source of anthocyanin and has  
anti-cancer and anti-viral properties10,11. Jamun 
possess antineoplastic12, radioprotective13,14,15,16 and 
chemopreventive effects17, all of which are useful in the 
prevention and treatment of cancer18. Jamun extract 
has been shown to be selectively cytotoxic to the 
human neoplastic breast cancer cells and it is logical 
to suggest that the constituents of jamun may have 
inhibited the process of carcinogenesis by selectively 
killing the mutated, preneoplastic and neoplastic cells 
resulting from the carcinogen treatment19. The present 
research work was undertaken to study in vitro 
anticancer potential of seed part of C. carandas and S. 
cumini against nine human cancer cell lines (A-498, 
A-549, HCT-116, MCF-7, MDA-MB-435, OVCAR-
5, PC-3, SF-295 and T-47D) from eight different 
tissues (renal, lung, colon, breast, melanoma, ovarian, 
prostate and CNS). ————— *Corresponding author 
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Methodology 
 Chemicals 
RPMI-1640 medium, dimethyl sulfoxide (DMSO), 
EDTA, fetal bovine serum (FBS), sulphorhodamine 
blue (SRB) dye, phosphate buffer saline (PBS), 
trypsin, gentamycin, penicillin and 5-flurouracil were 
purchased from Sigma Chemical Co., USA. All other 
chemicals were of high purity and obtained locally 
with the brand Sigma-Aldrich Chemicals Pvt. Ltd. 
and S.D. Fine Chemicals Pvt. Ltd. from Ramesh 
Traders, Panjthirthi-Jammu, J&K. 
 
Preparation of seed extracts 
C. carandas and S. cumini were authenticated at 
site by Dr Vijay Bahadhur Singh, I/c Rainfed 
Research Station for Subtropical Fruits (RRSSF), 
Raya, SKUAST-Jammuand enough quantity of fresh 
fruits were collected.The freshly collected fruits were 
chopped, seeds were taken out then shade-dried and 
ground into powdered form. The methanolic extracts 
of the seeds were prepared by percolating the dried 
ground plant material (100 g) with 95% methanol and 
then concentrating it to dryness under reduced 
pressure. Stock solutions of 20 mg/mL were prepared 
by dissolving 95% methanolic extract in DMSO. 
Stock solutions were prepared at least one day in 
advance and were not filtered. The microbial 
contamination was controlled by addition of 1% 
gentamycin in complete growth medium i.e., used for 
dilution of stock solutions to make working test 
solutions of 200 μg/mL. 
 
Cell lines/cultures and positive controls 
The human cancer cells-A-498 (renal), A-549 
(lung), HCT-116 (colon), MCF-7 (breast), MDA-MB-
435 (melanoma), OVCAR-5 (ovarian), PC-3 
(prostate) SF-295 (CNS) and T-47D (breast) were 
obtained from National Centre for Cell Science, Pune, 
India and National Cancer Institute, Frederick, USA. 
These human cancer cells were further grown and 
maintained in RPMI-1640 medium. Doxorubicin, 5-
Fluorouracil, Mitomycin-C, Paclitaxel and tamoxifen 
were used as positive controls. 
 
In vitro assay for cytotoxic activity 
Extracts were subjected to in vitro anticancer activity 
against various human cancer cell lines20. In brief, the 
cells were grown in tissue culture flasks in growth 
medium at 37oC in an atmosphere of 5% CO2 and 90% 
relative humidity in a CO2 incubator (Hera Cell, 
Heraeus; Asheville, NCI, USA). The cells at sub-
confluent stage were harvested from the flask by 
treatment with trypsin (0.05% trypsin in PBS containing 
0.02% EDTA) and suspended in growth medium. Cells 
with more than 97% viability (trypan blue exclusion) 
were used for determination of cytotoxicity. An aliquot 
of 100 μL of cells (105 cells/mL) was transferred to a 
well of 96-well tissue culture plate. The cells were 
allowed to grow for 24 h. Extracts (100 μL/well) were 
then added to the wells and cells were further allowed to 
grow for another 48 h.  
The anti-proliferative SRB assay which estimates 
cell number indirectly by staining total cellular 
protein with the dye SRB was performed to assess 
growth inhibition. The SRB staining method is 
simpler, faster and provides better linearity with cell 
number. It is less sensitive to environmental 
fluctuations and does not require a time sensitive 
measurement of initial reaction velocity21. In brief, the 
cell growth was stopped by gently layering 50 μL of 
50% (ice cold) trichloroacetic acid on the top of 
growth medium in all the wells. The plates were 
incubated at 4oC for 1 h to fix the cells attached to the 
bottom of the wells. Liquid of all the wells was then 
gently pipetted out and discarded. The plates were 
washed five-times with distilled water and air-dried. 
SRB 100 μL (0.4% in 1% acetic acid) was added to 
each well and the plates were incubated at room 
temperature for 30 min. 
The unbound SRB was quickly removed by 
washing the cells five-times with 1% acetic acid. 
Plates were air-dried, tris buffer (100 μL, 0.01 M, pH 
10.5) was added to all the wells to solubilize the dye 
and then plates were gently stirred for 5 min on a 
mechanical stirrer. The optical density (OD) was 
recorded on ELSIA reader at 540 nm. Suitable blanks 
(growth medium and DMSO) and positive controls 
(prepared in DMSO and distilled water) were also 
included. Each test was done in triplicate and the 
values reported were mean values of three 
experiments. 
The cell growth was determined by subtracting 
average absorbance value of respective blank from the 
average absorbance value of experimental set. Percent 
growth in presence of test material was calculated as 
under:  
 
 OD Change in presence of control=Mean OD of 
control–Mean OD of blank 
 OD Change in presence of test sample=Mean OD 
of test sample–Mean OD of blank 
 % Growth in presence of control=100/OD change 
in presence of control 
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 % Growth in presence of test sample=% Growth in 
presence of control×OD change in presence of test 
sample 
 % Inhibition by test sample=100–% Growth in 
presence of test sample 
 The growth inhibition of 70% or above was 
considered active while testing extracts, but in testing of 
active ingredients at different molar concentrations, the 
growth inhibition of 50% or above was the criteria of 
activity. 
 
Results and Discussion 
The seed extract of karonda at 100 μg/mL, showed 
strong in vitro cytotoxic effect against five human 
cancer cell lines from five different tissues namely 
HCT-116 (colon), A-549 (lung), MDA-MB-435 
(melanoma), OVCAR-5 (ovarian) and A-498 (renal). 
Maximum growth inhibition i.e., 100% was observed 
against A-549 and OVCAR-5 cancer cells. The seed 
showed 89% growth inhibition of HCT-116, 82% of 
MDA-MB-435 and 78% of A-498 cancer cells. The 
methanolic extract did not show any cytotoxic effect 
against other four human cancer cell lines as the growth 
inhibition against these human cancer cell lines was 
observed in the range of 63-67%, which is considered 
in-significant (Table 1). 67% growth inhibition was 
observed against T-47D (breast), 66% against SF-295 
(CNS), 65% against MCF-7 (breast) and 63% against 
PC-3 (prostate). At lower concentrations, karonda 
showed 95% growth inhibition at 50 μg/mL, 94% 
growth inhibition at 30 μg/mL and 87% growth 
inhibitionat 10 μg/mL against A-549 cancer cells. In 
case of MDA-MB-435, the growth inhibition observed 
was 79% at 50 μg/mL and 78% at 30 μg/mL whereas 
the extract also exhibited 86% growth inhibition at 50 
μg/mL against HCT-116 cancer cells (Table 2).  
Table 1 — Growth inhibitory effect of karonda seed along with positive controls against human cancer cells 
Growth inhibition of 70% or more in case of extracts has been indicated in bold numbers 
Generic name 
of the fruit 
Extract  
E Extract 
Conc. 
(µg/mL) 
Human cancer cell lines from eight different tissues 
Breast Breast CNS Colon Lung Melanoma Ovarian Prostate Renal 
MCF-7 T-47D SF-295 HCT-116 A-549 MDA-MB-435 OVCAR- 5 PC-3 A-498 
Growth Inhibition (%) 
Carissa 
carandas 
Methanolic 100 65 67 66 89 100 82 100 63 78 
Positive controls (standard drugs) Conc. 
(µM) 
 
Doxorubicin 1 - - 71 - - - - - - 
5-Fluorouracil 20 - - - 65 - - 70 - - 
Mitomycin-C 1 - - - - - - - 63 - 
Paclitaxel 1 77 72 - - 71 - - - 70 
Tamoxifen 1 - - - - - 75 - - - 
Mark (-) indicates that particular human cancer cell line was not treated with that particular positive control 
 
Table 2 — Growth inhibitory effect of karonda seed at lower concentrations against human cancer cells 
Growth inhibition of 70% or more in case of extracts has been indicated in bold numbers 
Generic name of the 
fruit 
Extract E Extract Conc.(µg/mL) Human cancer cell lines from five different tissues 
Colon Lung Melanoma Ovarian Renal 
HCT-116 A-549 MDA-MB-435 OVCAR-5 A-498 
Growth Inhibition (%) 
Carissa carandas Methanolic 50 86 95 79 0 39 
30 68 94 78 0 0 
10 61 87 44 0 0 
1 0 09 19 0 0 
Positive controls (standard drugs) Conc.(µM) 
Doxorubicin 1 - - - - - 
5-Fluorouracil 20 65 - - 70 - 
Paclitaxel 1 - 71 - - 70 
Tamoxifen 1 - - 75 - - 
Growth inhibition of 70% or more in case of extracts has been indicated in bold numbers 
Mark (-) indicates that particular human cancer cell line was not treated with that particular positive control 
Table 3 Growth inhibitory effect of jamun seed along with positive controls against human cancer cells 
Growth inhibition of 70% or more in case of extracts has been indicated in bold numbers 
INDIAN J TRADIT KNOWLE, JULY 2019 
 
 
576
Jamun seed extract at 100 μg/mL, exhibited 93% in 
vitro cytotoxic effect against SF-295 cancer cells. It 
showed 75% growth inhibition of A-498, 74% of 
HCT-116, 72% of A-549 and PC-3, 71 % of MDA-
MB-435 cancer cells. The extract did not exhibit any 
activity against other three human cancer cell lines as 
the growth inhibition was found in-significant  
(Table 3). 65% growth inhibition was observed 
against OVCAR-5 (ovarian), 61 against T-47D 
(breast) and 60% against MCF-7 (breast). When 
tested at lower concentrations, the extract showed 
84% growth inhibition at 50 μg/mL and 73% growth 
inhibition at 30 μg/mL against A-549 cancer cells. It 
also showed 74% growth inhibition at30 μg/mL 
against SF-295 cancer cells (Table 4). Further, IC50 
values were calculated and it was observed that seeds 
of both the fruits showed IC50< 10 in case of lung 
cancer cells whereas karonda also showed IC50< 10 in 
case of colon cancer cells (Fig. 1 & Fig. 2). 
Cancer is becoming a big load on families and 
economies. Epidemiological studies have shown that 
Table 3 — Growth inhibitory effect of jamun seed along with positive controls against human cancer cells 
Growth inhibition of 70% or more in case of extracts has been indicated in bold numbers 
Generic name 
of the fruit 
Extract  
E Extract 
Conc. 
(µg/mL) 
Human cancer cell lines from eight different tissues 
Breast Breast CNS Colon Lung Melanoma Ovarian Prostate Renal 
MCF-7 T-47D SF-295 HCT-116 A-549 MDA-MB-435 OVCAR- 5 PC-3 A-498 
Growth Inhibition (%) 
Syzygium 
cumini 
Methanolic 100 60 61 93 74 72 71 65 72 75 
Positive controls (standard 
drugs) 
Conc. 
(µM) 
 
Doxorubicin 1 - - 71 - - - - - - 
5-Fluorouracil 20 - - - 65 - - 70 - - 
Mitomycin-C 1 - - - - - - - 63 - 
Paclitaxel 1 77 72 - - 71 - - - 70 
Tamoxifen 1 - - - - - 75 - - - 
Mark (-) indicates that particular human cancer cell line was not treated with that particular positive control 
 
Table 4 — Growth inhibitory effect of jamun seed at lower concentrations against human cancer cells 
Growth inhibition of 70% or more in case of extracts, has been indicated in bold numbers 
Generic name 
of the fruit 
Extract  
E Extract 
Conc. (µg/mL) Human cancer cell lines from four different tissue 
CNS Colon Lung Melanoma Prostate Renal 
SF-295 HCT-116 A-549 MDA-MB-435 PC-3 A-498 
Growth inhibition (%) 
Syzygium 
cumini 
Methanolic 50 0 58 84 50 0 0 
30 74 50 73 21 0 0 
10 6 0 50 31 0 0 
1 6 0 0 54 0 27 
Positive controls (standard drugs) Conc.(µM)  
Doxorubicin 1 71 - - - - - 
5-Fluorouracil 20 - 65 - - - - 
Mitomycin-C 1 - - - - 63 - 
Paclitaxel 1 - - 71 - - 70 
Tamoxifen 1 - - - 75 - - 
The mark (-) indicates that particular human cancer cell line was not treated with that particular positive control 
  
Fig. 1 — IC50 values of karonda (Carissa carandas) seed extract 
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a large number of cancer related deaths could be 
prevented by increased consumption of fruits. High 
intake of fruits protect against various cancers and 
protective effects of high fruit consumption are 
attributed to vitamins/minerals and phytochemicals, 
that exhibit a potential for modulating human 
metabolism in a manner favorable for the prevention 
of cancer. Therefore, fruits consumed in our daily diet 
could be a solution to cancer and synergistic effects of 
phytochemicals in fruits are responsible for their 
potent antioxidant/anticancer activities. The Jammu 
region has diversity of subtropical fruits, however, 
only a relatively small number of fruits have been 
subjected to accepted scientific evaluation for their 
potential anticancer effects. Keeping this in mind, the 
present investigation was carried out to evaluate the in 
vitro anticancer potential of minor fruits from Jammu 
region against nine human cancer cell lines from eight 
different tissues. In vitro assay for cytotoxic activity 
was conducted by using SRB dye with appropriate 
positive controls and the results revealed that 
methanolic extracts from karonda and jamun showed 
(cell line specific) in vitro cytotoxic activity against 
human cancer cell lines. The data was compared with 
literature values and it was found that the data was in 
agreement with the published data. Extracts of 
karonda were investigated on human ovarian 
carcinoma, Caov-3 and lung cancer cells22.Chloroform 
extracts of C. carandas leaves exhibited cytotoxicity 
on human ovarian carcinoma cells and n-hexane 
extract of the unripe fruits is cytotoxic towards the 
lung cancer cell line23. S. cumini reduced the tumor 
incidence, tumor burden and cumulative number of 
gastric carcinomas24. Extract of jamun has been 
shown to be cytotoxic to human neoplastic breast 
cancer cells and have inhibited the process of 
carcinogenesis by selectively killing the mutated, 
preneoplastic and neoplastic cells resulting from the 
carcinogen treatment19. 
 
Conclusion 
To conclude, karonda and jamun seeds have shown 
remarkable activity against lung cancer cells (A-549) 
at lower concentrations, but karonda also shown 
significant result in case of melanoma and colon 
cancer cells. Karonda seeds showed IC50< 10 in case 
of lung and colon cancer cells whereas jamun showed 
IC50=10 against lung cancer cells. In the present 
research work, an attempt was made to elucidate the 
in vitro anticancer potential of minor fruits from 
Jammu region. The results obtained from our 
investigation confirmed the therapeutic potency of 
karonda and jamun especially against lung cancer 
cells. The results also showed that these fruits possess 
certain cytotoxic constituents that can be used for 
developing anticancer agents for lung cancer therapy. 
Moreover, it forms a good basis for the selection of 
seed part of these fruits for further phytochemical and 
pharmacological analysis and offer us new drugs from 
natural sources which would be less toxic and more 
potent for the efficient management of cancer.  
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